Cantor Fitzgerald restated their overweight rating on shares of Orchard Therapeutics (NASDAQ:ORTX – Get Rating) in a report released on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Orchard Therapeutics’ FY2023 earnings at ($6.25) EPS. Separately, Oppenheimer increased their price target on Orchard Therapeutics from $5.00 to $37.00 in a research note on Monday, […]
Capital Advisors Wealth Management LLC grew its holdings in shares of Global X Cybersecurity ETF (NASDAQ:BUG – Get Rating) by 3.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 56,756 shares of the company’s stock after acquiring an additional 1,964 shares during the quarter. Capital Advisors Wealth Management LLC’s holdings in Global […]
Investment analysts at StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, Piper Sandler reissued a “neutral” rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals […]
Sowell Financial Services LLC grew its stake in Invesco PureBeta 0-5 Yr US TIPS ETF (BATS:PBTP – Get Rating) by 10.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 66,102 shares of the company’s stock after purchasing an additional 6,284 […]
Capital Analysts LLC lowered its stake in shares of Invesco S&P 500 Revenue ETF (NYSEARCA:RWL – Get Rating) by 88.8% during the fourth quarter, Holdings Channel reports. The fund owned 600 shares of the company’s stock after selling 4,750 shares during the period. Capital Analysts LLC’s holdings in Invesco S&P 500 Revenue ETF were worth […]